Patients on a widely-used high blood pressure medication are being urged to verify their pills after the manufacturer, Recordati Pharmaceuticals, reported a misprint regarding the dosage strength on some packages. A specific batch of Lercanidipine has been incorrectly labelled as 10mg tablets when they are in fact 20mg.